Table 1.
IRR of acute myocardial infarction following COVID-19 in the SCCS
| Number of events | IRR (95% CI) | p value | |
|---|---|---|---|
| Acute myocardial infarction analysis 1 (day 0 out of the risk period) | |||
| Control period | 90 | 1 (ref) | .. |
| Buffer period: days −28 to −4 | 30 | 2·04 (1·30–3·21) | 0·0021 |
| Pre-exposure period: days −3 to 0 | 30 | 16·20 (10·24–25·63) | <0·0001 |
| Risk period: days 1 to 7 | 12 | 2·89 (1·51–5·55) | 0·0014 |
| Risk period: days 8 to 14 | 12 | 2·53 (1·29–4·94) | 0·0067 |
| Risk period: days 15 to 28 | 12 | 1·60 (0·84–3·04) | 0·16 |
| Acute myocardial infarction analysis 2 (day 0 in the risk period) | |||
| Control period | 90 | 1 (ref) | .. |
| Buffer period: days −28 to −4 | 30 | 2·06 (1·31–3·24) | 0·0017 |
| Pre-exposure period: days −3 to −1 | 3 | 2·52 (0·78–8·09) | 0·12 |
| Risk period: days 0 to 7 | 39 | 8·44 (5·45–13·08) | <0·0001 |
| Risk period: days 8 to 14 | 12 | 2·56 (1·31–5·01) | 0·0059 |
| Risk period: days 15 to 28 | 12 | 1·62 (0·85–3·09) | 0·14 |
IRR=incidence rate ratio. SCCS=self-controlled case series.